- Report
- March 2025
- 50 Pages
Germany
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
France
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Mexico
From €550EUR$600USD£467GBP
- Report
- March 2025
- 50 Pages
Canada
From €550EUR$600USD£467GBP
- Report
- August 2023
- 1300 Pages
Global
From €8153EUR$8,900USD£6,929GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4489EUR$4,900USD£3,815GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4489EUR$4,900USD£3,815GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4489EUR$4,900USD£3,815GBP
- Report
- August 2023
- 300 Pages
Europe
From €4489EUR$4,900USD£3,815GBP
- Report
- August 2023
- 51 Pages
South Korea
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
India
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
Mexico
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
Australia
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
Japan
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
United States
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
Argentina
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
Brazil
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
Italy
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
China
From €550EUR$600USD£467GBP
- Report
- August 2023
- 51 Pages
Spain
From €550EUR$600USD£467GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more